A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 106
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : CSF-1R
Long Form : CSF-1 receptor
No. Year Title Co-occurring Abbreviation
2022 Radiolabeled Monoclonal Antibody Against Colony-Stimulating Factor 1 Receptor Specifically Distributes to the Spleen and Liver in Immunocompetent Mice. 89Zr, CSF-1, mAbs, N-suc-DFO
2021 Contribution of colony-stimulating factor 1 to neuropathic pain. CSF-1
2021 CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment. BMDMs, CSF-1, FDA, TAMs, TCM
2021 CSF1R Inhibition Combined with GM-CSF Reprograms Macrophages and Disrupts Protumoral Interplays with AML Cells. AML
2021 Defects in Macrophage Reprogramming in Cancer Therapy: The Negative Impact of PD-L1/PD-1. CSF-1, HDAC, PD-L1, TLR7
2021 Epithelial-Macrophage Crosstalk Initiates Sterile Inflammation in Embryonic Skin. DAMPs, Itgbeta1, NGS
2021 IL-34, the rationale for its expression in physiological and pathological conditions. PTP
2021 LY3022855, an anti-colony stimulating factor-1 receptor (CSF-1R) monoclonal antibody, in patients with advanced solid tumors refractory to standard therapy: phase 1 dose-escalation trial. CSF-1, Q2W, TAMs
2021 MEOX2 serves as a novel biomarker associated with macrophage infiltration in oesophageal squamous cell carcinoma and other digestive system carcinomas. CSF-1, DEGs, ESCC, GEO, ssGSEA, WGCNA
10  2021 PLX3397, a CSF1 receptor inhibitor, limits allotransplantation-induced vascular remodeling. CSF-1, GVD, SMLCs
11  2021 Targeting the CSF1/CSF1R axis is a potential treatment strategy for malignant meningiomas. CSF-1, mAbs, PD-1, PD-L1, TME
12  2021 Unlike Brief Inhibition of Microglia Proliferation after Spinal Cord Injury, Long-Term Treatment Does Not Improve Motor Recovery. CSF-1
13  2020 CSF1R Is Required for Differentiation and Migration of Langerhans Cells and Langerhans Cell Histiocytosis. DC, LC, LCH, TAM
14  2020 FXIIIa substrate peptide decorated BLZ945 nanoparticles for specifically remodeling tumor immunity. A15-BLZ-NPs, BLZ945-PLA, CA4-NPs
15  2020 Rh-CSF1 attenuates neuroinflammation via the CSF1R/PLCG2/PKCepsilon pathway in a rat model of neonatal HIE. CREB, CSF-1, HIE, PKCepsilon, PLCG2, rh-CSF1
16  2020 Rh-CSF1 Attenuates Oxidative Stress and Neuronal Apoptosis via the CSF1R/PLCG2/PKA/UCP2 Signaling Pathway in a Rat Model of Neonatal HIE. CSF-1, HIE, OS, PLCG2, rh-CSF1, UCP2
17  2020 Targeting colony stimulating factor-1 receptor signalling to treat ectopic pregnancy. CSF-1
18  2019 Colony-stimulating factor-1- and interleukin-34-derived macrophages differ in their susceptibility to Mycobacterium marinum. Mtb, TB
19  2019 Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade. CSF-1, HCC, OPN, PD-L1, TAMs, Th1
20  2019 Functional evolution of the colony-stimulating factor 1 receptor (CSF1R) and its ligands in birds. CSF1R, IL34
21  2019 Macrophages in the microenvironment of head and neck cancer: potential targets for cancer therapy. CSF-1, TAMs
22  2019 Microglia Mediate Synaptic Material Clearance at the Early Stage of Rats With Retinitis Pigmentosa. OPL, RBCs, RCS, RP
23  2019 MicroRNA-148b-colony-stimulating factor-1 signaling-induced tumor-associated macrophage infiltration promotes hepatocellular carcinoma metastasis. CSF-1, HCC, miRNAs, TAM
24  2019 Surface Modification of Polymeric Nanoparticles with M2pep Peptide for Drug Delivery to Tumor-Associated Macrophages. CSF-1, TAMs
25  2018 CSF1R Inhibition Reduces Microglia Proliferation, Promotes Tissue Preservation and Improves Motor Recovery After Spinal Cord Injury. CSF-1, HS, MRI, SCI
26  2018 CSF1R-dependent myeloid cells are required for NK‑mediated control of metastasis. ---
27  2018 Effects of IL-10 and Th 2 cytokines on human Mphi phenotype and response to CSF1R inhibitor. ---
28  2018 Interleukin-34, a comprehensive review. PTP-zeta
29  2018 Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial. CSF-1
30  2018 Tenosynovial giant cell tumor: case report of a patient effectively treated with pexidartinib (PLX3397) and review of the literature. TGCTs
31  2018 The RUNX1/IL-34/CSF-1R axis is an autocrinally regulated modulator of resistance to BRAF-V600E inhibition in melanoma. ---
32  2017 First-in-Human Study of AMG 820, a Monoclonal Anti-Colony-Stimulating Factor 1 Receptor Antibody, in Patients with Advanced Solid Tumors. AE, AST, CSF-1
33  2017 Identification of the macrophage-specific promoter signature in FANTOM5 mouse embryo developmental time course data. CAGE, dhrs3, dpc, EMR-1, Siglec5, Timd4, VSIG4
34  2017 Interaction between astrocytic colony stimulating factor and its receptor on microglia mediates central sensitization and behavioral hypersensitivity in chronic post ischemic pain model. CPIP, CSF-1, IR
35  2016 A Zebrafish Live Imaging Model Reveals Differential Responses of Microglia Toward Glioblastoma Cells In Vivo. ---
36  2016 Co-inhibition of colony stimulating factor-1 receptor and BRAF oncogene in mouse models of BRAFV600E melanoma. CSF-1, MDSCs
37  2016 Diffuse-type tenosynovial giant cell tumour: Current treatment concepts and future perspectives. CSF-1, D-TGCT
38  2016 Receptor-Type Protein-Tyrosine Phosphatase zeta and Colony Stimulating Factor-1 Receptor in the Intestine: Cellular Expression and Cytokine- and Chemokine Responses by Interleukin-34 and Colony Stimulating Factor-1. CSF-1, IBD, IFN-gamma, IL, MCP-1, PBMCs, TNF-alpha
39  2015 Colony stimulating factor 1 receptor inhibition delays recurrence of glioblastoma after radiation by altering myeloid cell recruitment and polarization. CSF-1, GBM, IR
40  2015 CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study. CSF-1, dt-GCT
41  2015 Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition. CSF-1, MDSC, TIL, TIM
42  2015 Injured sensory neuron-derived CSF1 induces microglial proliferation and DAP12-dependent pain. CSF-1
43  2015 Interleukin 34: a new modulator of human and experimental inflammatory bowel disease. CD, CSF-1, IBD, UC
44  2015 Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor. CSF-1
45  2015 The development and maintenance of the mononuclear phagocyte system of the chick is controlled by signals from the macrophage colony-stimulating factor receptor. IL34
46  2014 CSF-1 receptor signaling in myeloid cells. CSF-1, IL-34
47  2014 CSF-1R signaling in health and disease: a focus on the mammary gland. CSF-1, M-CSF, TAMs
48  2014 Inhibition of CSF-1R supports T-cell mediated melanoma therapy. TAM
49  2014 Targeting cell-intrinsic and cell-extrinsic mechanisms of intravasation in invasive breast cancer. CSF-1
50  2014 Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy. CSF-1, Dt-GCT
51  2013 Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival. CREB, CSF-1, CSF1R, IL-34
52  2013 CSF-1R inhibition alters macrophage polarization and blocks glioma progression. CSF-1, GBM, GM-CSF, IFN-gamma, TAMs
53  2013 IL-34 and CSF-1: similarities and differences. CSF-1, DCs, IL-34, LCs
54  2013 Inhibition of CSF-1 receptor improves the antitumor efficacy of adoptive cell transfer immunotherapy. ACT, CSF-1, MDSC, TIL, TIM
55  2013 Specific inhibition of PI3K p110delta inhibits CSF-1-induced macrophage spreading and invasive capacity. CSF-1, PI3K, pY721
56  2013 The CSF-1 receptor fashions the intestinal stem cell niche. GI, KO, PCs, SI
57  2012 CSF-1 receptor signalling from endosomes mediates the sustained activation of Erk1/2 and Akt in macrophages. CSF-1
58  2012 Macrophage proliferation is regulated through CSF-1 receptor tyrosines 544, 559, and 807. CSF-1, JMD, PI3K, SFK
59  2012 PSTPIP2 deficiency in mice causes osteopenia and increased differentiation of multipotent myeloid precursors into osteoclasts. PSTPIP2
60  2012 Spleen serves as a reservoir of osteoclast precursors through vitamin D-induced IL-34 expression in osteopetrotic op/op mice. 2MD, CSF-1, OCPs, OP, RANK, RANKL
61  2012 The CSF-1 receptor ligands IL-34 and CSF-1 exhibit distinct developmental brain expression patterns and regulate neural progenitor cell maintenance and maturation. ---
62  2011 Control of macrophage lineage populations by CSF-1 receptor and GM-CSF in homeostasis and inflammation. GM, mAb
63  2011 Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis. CSF-1, IM, PVNS, TGCT
64  2011 Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. CSF-1
65  2011 Phosphorylation of CSF-1R Y721 mediates its association with PI3K to regulate macrophage motility and enhancement of tumor cell invasion. CSF-1, PI3K, PLC
66  2011 The role of atypical protein kinase C in CSF-1-dependent Erk activation and proliferation in myeloid progenitors and macrophages. BMMs
67  2011 Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. CSF-1
68  2010 A CSF-1 receptor phosphotyrosine 559 signaling pathway regulates receptor ubiquitination and tyrosine phosphorylation. CSF-1, RTK, SFKs
69  2009 Colony stimulating factor-1 dependence of paneth cell development in the mouse small intestine. CSF-1, PCs
70  2009 Colony-stimulating factor-1-induced oscillations in phosphatidylinositol-3 kinase/AKT are required for caspase activation in monocytes undergoing differentiation into macrophages. CSF-1
71  2009 JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia. CSF-1, FLT3
72  2009 Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy. MDSCs, TAMs, TIMs
73  2008 Distinct roles of class IA PI3K isoforms in primary and immortalised macrophages. CSF-1
74  2008 The Ewing sarcoma protein (EWS) binds directly to the proximal elements of the macrophage-specific promoter of the CSF-1 receptor (csf1r) gene. CAGE, EWS, MZF-1, TSS
75  2007 PU.1 and ICSBP control constitutive and IFN-gamma-regulated Tlr9 gene expression in mouse macrophages. BMM, CpG DNA, IRF
76  2006 T-cell protein tyrosine phosphatase (Tcptp) is a negative regulator of colony-stimulating factor 1 signaling and macrophage differentiation. CSF-1, GMP
77  2006 Transgenic expression of CSF-1 in CSF-1 receptor-expressing cells leads to macrophage activation, osteoporosis, and early death. ---
78  2005 A proteomics strategy for the enrichment of receptor-associated complexes. ---
79  2004 A novel 110 kDa form of myosin XVIIIA (MysPDZ) is tyrosine-phosphorylated after colony-stimulating factor-1 receptor signalling. ---
80  2002 Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. CSF-1
81  2000 Both src-dependent and -independent mechanisms mediate phosphatidylinositol 3-kinase regulation of colony-stimulating factor 1-activated mitogen-activated protein kinases in myeloid progenitors. CSF-1, ERK, PI 3-kinase, SFKs, WT
82  1999 CSF-1 activates MAPK-dependent and p53-independent pathways to induce growth arrest of hormone-dependent human breast cancer cells. ---
83  1999 Direct comparison of the effects of CSF-1 (M-CSF) and GM-CSF on human monocyte DNA synthesis and CSF receptor expression. GM-CSF
84  1999 Regulation by Gi2 proteins of v-fms-induced proliferation and transformation via Src-kinase and STAT3. STAT3
85  1999 Separation and characterization of the activated pool of colony-stimulating factor 1 receptor forming distinct multimeric complexes with signalling molecules in macrophages. CSF-1, PI-3 kinase
86  1999 The Cbl protooncoprotein stimulates CSF-1 receptor multiubiquitination and endocytosis, and attenuates macrophage proliferation. CSF-1
87  1998 Colony-stimulating factor-1 stimulates the formation of multimeric cytosolic complexes of signaling proteins and cytoskeletal components in macrophages. CSF-1, pY
88  1998 DMSO reduces CSF-1 receptor levels and causes apoptosis in v-myc immortalized mouse macrophages. CSF-1, DMSO
89  1997 Biology and action of colony--stimulating factor-1. CSF-1
90  1997 CSF-1 and its receptor in breast carcinomas and neoplasms of the female reproductive tract. ---
91  1996 Hyperglycemia augments macrophage growth responses to colony-stimulating factor-1. CSF-1
92  1996 Regulation of colony-stimulating factor 1 receptor signaling by the SH2 domain-containing tyrosine phosphatase SHPTP1. CSF-1
93  1994 Expression of transcripts for CSF-1 and for the "macrophage" and "epithelial" isoforms of the CSF-1R transcripts in human ovarian carcinomas. ---
94  1993 Expression of functional human CSF-1 receptors on mouse bone marrow erythroid progenitor cells. ---
95  1993 Expression of human colony-stimulating factor-1 (CSF-1) receptor in murine pluripotent hematopoietic NFS-60 cells induces long-term proliferation in response to CSF-1 without loss of erythroid differentiation potential. CSF-1, SCF
96  1993 Expression of the colony stimulating factor-1 receptor (c-fms product) by cells at the human uteroplacental interface. CSF-1
97  1992 Activation of the colony-stimulating factor 1 receptor leads to the rapid tyrosine phosphorylation of GTPase-activating protein and activation of cellular p21ras. bFGF, CSF-1, GAP, PDGF
98  1992 IFN-gamma/lipopolysaccharide activation of macrophages is associated with protein kinase C-dependent down-modulation of the colony-stimulating factor-1 receptor. ---
99  1992 Mitogenic signaling by colony-stimulating factor 1 and ras is suppressed by the ets-2 DNA-binding domain and restored by myc overexpression. CSF-1
100  1991 A mutational analysis of phosphatidylinositol-3-kinase activation by human colony-stimulating factor-1 receptor. CSF-1, KI, PtdIns-3-kinase